What are the causes and management options for subcutaneous atrophy?

Subcutaneous Atrophy: Causes and Management

Primary Causes

Subcutaneous atrophy results most commonly from iatrogenic corticosteroid administration, age-related vascular degeneration, or idiopathic lipodystrophy. 1, 2, 3

Corticosteroid-Induced Atrophy

• Intramuscular or intralesional corticosteroid injections are the most frequent iatrogenic cause, particularly with less water-soluble preparations like triamcinolone acetonide 2, 3
• Risk factors include young age (especially women and girls), use of high-potency steroids, and injection into areas with thin subcutaneous tissue 1, 3
• Atrophy typically appears within days to weeks after injection and may persist for years or become permanent 2, 3
• Topical corticosteroid-induced atrophy occurs with prolonged use of high-potency preparations, particularly on thin skin areas (face, intertriginous regions) and with occlusion 1

Age-Related Vascular Atrophy

• Decreased blood flow from vascular degeneration is the primary mechanism, causing inadequate oxygen and nutrient supply to subcutaneous adipose tissue 1, 4
• Hyperactive sympathetic signals contribute to progressive atrophy by reducing perfusion to deep fat compartments 4
• Regions with naturally low fat distribution (periorbital, perioral areas) show earliest and most visible signs 1
• This process decreases collagen synthesis, cell division rates, and impairs tissue regeneration capacity 1

Idiopathic Lipodystrophy

• Focal disappearance of subcutaneous fat without inflammatory signs or identifiable triggers 5
• Most commonly affects thighs, abdomen, or ankles 5
• Diagnosis requires exclusion of autoimmune disease, infection (Borrelia), trauma, and medication causes 5

---

Management Approach

For Corticosteroid-Induced Atrophy

Normal saline infiltration is the first-line treatment for persistent corticosteroid-induced subcutaneous atrophy, offering rapid and complete resolution in most cases. 6

Saline Infiltration Protocol

• Inject bacteriostatic normal saline directly into the atrophic site weekly 6
• Use volumes of 5-20 mL per treatment session based on defect size 6
• Expect complete resolution within 4-8 weeks (typically 3-6 treatment sessions) 6
• This approach is safe, well-tolerated, and highly effective with excellent patient satisfaction 6

Alternative Treatment Options

• Autologous blood injection (ABI): Inject 4 mL of freshly drawn peripheral blood into superficial, middle, and deep portions of atrophic tissue 2

  • Expect marked improvement after 2 sessions 2
  • Stimulates tissue healing through cellular and humoral mediators 2
  • Simpler and less expensive than platelet-rich plasma 2

• Autologous fat grafting: Reserved for cases unresponsive to conservative measures after 1 year 7

  • More invasive but provides superior cosmetic outcomes for persistent defects 7
  • Particularly useful for larger volume deficits 7

Prevention Strategies

• Use the lowest effective corticosteroid potency for the shortest duration 1
• Avoid high-potency steroids on thin skin areas (face, neck, intertriginous regions, periocular areas) 1
• Minimize periocular steroid use due to additional risks of cataracts and glaucoma 1
• For intralesional injections, use small volumes, avoid high injection pressures, and ensure proper technique to prevent retrograde flow 1
• Rotate injection sites and avoid repeated injections in the same location 1

---

For Age-Related Vascular Atrophy

Platelet-rich fibrin (PRF) therapy is the most effective strategy for age-related subcutaneous atrophy, as it directly addresses the underlying vascular degeneration. 1

Regenerative Treatment Options

• PRF injections: Target vascular degeneration by improving blood flow and stimulating tissue regeneration 1
• Fat grafting: Restores volume loss in deep fat compartments, particularly effective for periorbital and perioral regions 1
• Focus treatment on "hot spot" areas with low baseline fat distribution (around eyes and lips) where aging signs appear earliest 1

Addressing Contributing Factors

• Evaluate and modify UV exposure, smoking status, and other factors affecting blood flow 1
• Recognize that visible surface changes (wrinkles, laxity) reflect deeper tissue-level pathology requiring volumetric correction 1

---

For Idiopathic Lipodystrophy

No established effective treatment exists for idiopathic lipodystrophy; lesions typically stabilize but do not resolve spontaneously. 5

• Autologous fat grafting may be considered for cosmetic improvement, though efficacy is unproven 5
• Monitor for progression and reassess for secondary causes if clinical course changes 5

---

Critical Pitfalls to Avoid

• Do not assume corticosteroid-induced atrophy will spontaneously resolve—while some cases improve within 1 year, many persist indefinitely without intervention 3, 7
• Do not delay treatment beyond 6 months if no spontaneous improvement occurs 2
• Avoid intralesional steroids for periocular lesions due to risk of central retinal artery embolism, even with precautions 1
• Do not use topical corticosteroids continuously on facial or intertriginous skin without rotation strategies or steroid-sparing agents 1
• Recognize that hypopigmentation and full-thickness necrosis can accompany subcutaneous atrophy from corticosteroid injections 1